Last reviewed · How we verify

NCT03830242

Diagnostic Significance of FDG PET/CT Dynamic Imaging in Detecting Metastatic Lymph Nodes With Papillary Thyroid Cancer.

Status unknown NA Last updated 28 July 2022
What this trial tests

NA trial testing <Sup>18<Sup>F-FDG PET/CT dynamic scan in Positron-Emission Tomography in 50 participants. Status unknown.

Timeline
1 November 2018
Primary endpoint
31 December 2023
31 December 2024

Quick facts

Lead sponsorFifth Affiliated Hospital, Sun Yat-Sen University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposediagnostic
Enrollment50
Start date1 November 2018
Primary completion31 December 2023
Estimated completion31 December 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Fifth Affiliated Hospital, Sun Yat-Sen University

Who can join

Adults 18 to 65, any sex, with Positron-Emission Tomography or Lymph Node Metastases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to make up for the gap by performing a dynamic scan of \<Sup\>18\<Sup\>F-FDG PET/CT on newly diagnosed patients with papillary thyroid carcinoma. Pathological and genomic studies are performed. The differences between metastatic central lymph nodes images and tissues are compared at the same time. \<Sup\>18\<Sup\>F-FDG PET/CT dynamic imaging is explored in metastatic central lymph nodes with papillary thyroid cancer for the diagnostic value.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Positron-Emission Tomography

Currently open trials in the same condition.

Other Fifth Affiliated Hospital, Sun Yat-Sen University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03830242.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing